Bassani L. De Miranda
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.
Journal: European journal of pharmacology
Published: February 21, 2026
Cephalochromin Effects in Triple-Negative Breast Cancer Cells: Apoptosis Induction and Modulation of Survival Pathways.
Journal: Journal of natural products
Published: December 04, 2025
Autophagy inhibition potentiates the antileukemic effect of FLT3 inhibitors and overcomes resistance in FLT3-ITD acute myeloid leukemia.
Journal: Cell death discovery
Published: October 14, 2025
Screening for Antileukemia Agents in FMS-like Tyrosine Kinase 3 (FLT3)-Mutated Acute Myeloid Leukemia Cells.
Journal: ACS pharmacology & translational science
Published: April 29, 2025
Eribulin exerts multitarget antineoplastic activity in glioma cells.
Journal: Pharmacological reports : PR
Published: January 18, 2025
Cyclopenta[b]indoles as novel antimicrotubule agents with antileukemia activity.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: April 02, 2024
Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells.
Journal: Clinics (Sao Paulo, Brazil)
Published: February 01, 2024
Pharmacological Inhibition of PIP4K2 Potentiates Venetoclax-Induced Apoptosis in Acute Myeloid Leukemia.
Journal: International journal of molecular sciences
Published: October 31, 2023
NT157 exhibits antineoplastic effects by targeting IRS and STAT3/5 signaling in multiple myeloma.
Journal: Hematology, transfusion and cell therapy
Published: October 31, 2023
Antineoplastic effects of pharmacological inhibitors of aurora kinases in CSF3RT618I-driven cells.
Journal: Blood cells, molecules & diseases
Published: July 16, 2023
Last Updated: 09/26/2026